CENPC: A Potential Drug Target and Biomarker for Chromosomal Abnormalities

Target Name: CENPC

NCBI ID: G1060

CENPC: A Potential Drug Target and Biomarker for Chromosomal Abnormalities

Introduction

Chromosomal abnormalities, such as Down syndrome, are the most common genetic disorders affecting humans, affecting approximately 1 in 8 individuals worldwide. These disorders are caused by alterations in the chromosomes, leading to the development of abnormalities in gene function and the structure of the chromosome . One of the most common genetic abnormalities is the presence of an extra chromosome, known as a chromosomal abnormality. Chromosomal abnormalities can result from various causes, including errors in DNA replication, fusion, or transcription.

The CENPC protein

The CENPC (Interphase Centromere Complex Protein 7) protein is a key regulator of chromosomal stability and normal gene function. It is a 21-kDa protein that is located at the centromere region of chromosomes, where the protein plays a critical role in the regulation of microtubules of the mitotic spindle, which pulls the sister chromatids apart during mitosis or meiosis. The CENPC protein helps to ensure that each chromosome is correctly coiled and that the spindle is properly organized during cell division.

Mutations in the CENPC gene

Mutations in the CENPC gene have been identified as a cause of various chromosomal abnormalities, including Down syndrome. These mutations can result in the production of an abnormally complex protein, leading to the development of chromosomal abnormalities. Studies have shown that individuals with Down syndrome are more likely to have mutations in the CENPC gene compared to individuals without the disorder.

The potential for CENPC as a drug target

The CENPC protein is a potential drug target for the treatment of chromosomal abnormalities, including Down syndrome. Drugs that can modulate the activity of the CENPC protein, such as those that inhibit microtubule formation or that can alter the stability of chromosomes, may have therapeutic benefits for individuals with chromosomal abnormalities.

The CENPC gene has also been implicated in the development of various other genetic disorders, including leukemia and neurodegenerative diseases. Therefore, targeting the CENPC protein with drugs that can modulate its activity may have implications for the treatment of these disorders as well.

The CENPC protein as a biomarker

The CENPC protein is also a potential biomarker for chromosomal abnormalities. Since the CENPC protein is a key regulator of chromosomal stability and normal gene function, changes in its activity can indicate the presence of chromosomal abnormalities. Therefore, measuring the expression or activity of the CENPC protein can be a useful diagnostic tool for individuals with chromosomal abnormalities.

Chromosomal abnormalities can be detected using various techniques, including chromosomal staining, fluorescence in situ hybridization, and DNA sequencing. These techniques can provide information about the number and type of chromosomal abnormalities present in an individual. However, these techniques may not be able to provide information about the specific function of each chromosomal abnormality. Therefore, biomarkers that can provide information about the function of chromosomal abnormalities, such as the CENPC protein, may be useful for the diagnosis and treatment of these disorders.

Conclusion

The CENPC protein is a key regulator of chromosomal stability and normal gene function. It is a potential drug target for the treatment of chromosomal abnormalities, including Down syndrome, and a potential biomarker for these disorders. Further research is needed to understand the function of the CENPC protein and its potential as a therapeutic agent.

Protein Name: Centromere Protein C

Functions: Component of the CENPA-NAC (nucleosome-associated) complex, a complex that plays a central role in assembly of kinetochore proteins, mitotic progression and chromosome segregation. The CENPA-NAC complex recruits the CENPA-CAD (nucleosome distal) complex and may be involved in incorporation of newly synthesized CENPA into centromeres. CENPC recruits DNA methylation and DNMT3B to both centromeric and pericentromeric satellite repeats and regulates the histone code in these regions

More Common Targets